JESSICA DAVIS: Open Payments
NPI 1174378426 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 16 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $466 · 2025 $764
Food & beverage: $665Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $372 |
| Janssen Biotech, Inc. | 1 | $106 |
| Stemline Therapeutics Inc. | 1 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $32 |
| Genentech USA, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $21 |
Products named: Jakafi, RYBREVANT, ELZONRIS, Vyloy, Polivy, IMBRUVICA, MONJUVI, NINLARO.
Industry payments across OH — which companies pay providers there.
